Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resig... ( FRAZER Pa. Jan. 8 /- Cephalo...)

Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position

Date:1/8/2010

FRAZER, Pa., Jan. 8 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) today announced that effective February 5, 2010, Robert P. Roche, Jr., Executive Vice President of Worldwide Pharmaceutical Operations, will resign his position with the company to pursue other longstanding interests. During his tenure, Mr. Roche established and grew the Cephalon sales and marketing organization into a global business that exceeded $2 billion in annual sales revenue. The company will announce plans for its leadership and the commercial organization in the near future. Additionally, the global commercial leadership team, Alain Aragues, President of Cephalon Europe, Paul Li, Senior Vice President of International Pharmaceutical Operations, and Robert Repella, Senior Vice President of U.S. Pharmaceutical Operations, will continue to lead their respective organizations.

"Bob Roche made a tremendous contribution to the worldwide commercial success of Cephalon. On behalf of the board of directors and executive team, I want to express my appreciation for his 15 years of excellent service and leadership in establishing Cephalon as one of the leading biopharmaceutical companies in the world," said Frank Baldino, Jr., Ph.D., Chairman and CEO. "Bob built strong global sales and marketing organizations and we remain enthusiastic about our growth opportunities and the future of our company."

Since 1995, Mr. Roche has led the worldwide commercial organization which now has more than 30 products. He was promoted to Senior Vice President, Worldwide Pharmaceutical Operations, in 2000, and named an Executive Vice President in 2005. Before joining Cephalon, Mr. Roche served as Director and Vice President, Worldwide Strategic Product Development, for SmithKline Beecham's central nervous system and gastrointestinal products busine
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
2. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
3. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
4. Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
5. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
6. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
7. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
10. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
11. Cephalon Signs Option Agreement to Acquire Ception Therapeutics

Post Your Comments:

(Date:5/22/2013)... , May 22, 2013 Avanir Pharmaceuticals, Inc. (NASDAQ: ... an overview of the company at the following conferences. ... , Presentation date: Wednesday May 29, 2013 , Presentation ... Global Healthcare Conference , Presentation date: Wednesday June 5, ... A live webcast and 30-day archive ...

(Date:5/22/2013)... , May 22, 2013 Flagship Ventures, a ... on healthcare and sustainability, today announced the appointment ... a Senior Partner. In this role, Mr. Bancel ... companies. In addition to working closely ... also serves as President and Chief Executive Officer ...

(Date:5/22/2013)... -- Grifols, a global healthcare company based in ... demonstrating that a higher dose of PROLASTIN © -C ... alpha 1 protein in patients with alpha 1 ... the normal range for healthy individuals. AAT deficiency is ... the alpha 1 proteinase inhibitor (A1PI) protein can ...

Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2 Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2 Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4

[0] Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences [0] Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures [0] Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency

... ANN ARBOR, Mich., June 19 ... change interventions with outcomes, announced a,new research ... Insomnia and Overcoming(TM) Depression online behavior,change interventions ... Aetna,s,large employer members. Together, HealthMedia and Aetna ...

... safety and effectiveness of using cloned cells alone ... ... use of a human patient,s cloned infection-fighting T cells as,the sole therapy ... Cassian Yee, M.D., an associate member of the,Clinical Research Division at Fred ...

Cached Medicine Technology:HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 2 HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 3 HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 4 Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 2 Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 3

HealthMedia and Aetna to Study Online Insomnia and Depression Interventions Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation

(Date:5/22/2013)... CORVALLIS, Ore. A new study shows there is ... self-control in American young children one that does ... In the United States, girls had higher levels of ... to control their behavior and impulses, follow directions, and ... academic performance and college completion, in past studies by ...

(Date:5/22/2013)... May 22, 2013 DePuy Pinnacle ... DePuy Pinnacle Hip Replacement System continue to move forward ... Bernstein Liebhard LLP reports. According to an Order ... to produce monitoring reports associated with a 2007 criminal ... device marketing practices. Plaintiffs maintained in their ...

(Date:5/22/2013)... Twenty student-led startup companies at Arizona ... an intensive startup accelerator designed to help them execute ... create local jobs as part of ASU’s Edson ... initiative offers approximately 20 student teams up to $20,000 ... to launch their for-profit, more-than-profit or nonprofit ventures. The ...

(Date:5/22/2013)... the next two decades, the cost of treating strokes ... double, topping more than $180 billion a year, according ... increase: an aging population. The report, from the American ... published May 22 in the journal Stroke . ... Dr. Bruce Ovbiagele, chairman of the department of neurology ...

(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... has established the Westchester Lung Nodule Center for ... or receive lung cancer care. Lung cancer is the deadliest ... year, more people in the U.S. die from lung cancer ... As with all cancers, early detection increases survival rates. ...

[0] 'Boys will be boys' in US, but not in Asia [0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report [0] Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care

... of Medical Records Into a User,s ... ... UNIVAL, Inc., a healthcare,company that delivers a variety of integrated ... the Microsoft,HealthVault platform. HealthVault lets consumers collect, store, and share,health ...

... A new video blog will document one woman,s fight to end the ... participants of The Diabetes Challenge, a contest hosted by the Lifestyle Center ... ... -- A new video blog will document one woman,s fight to end ...

... Breast Cancer Awareness Month. And, there,s no better time than the present ... to become more informed about how the disease could affect you, your ... ... October 23, 2008 -- Last year, over 2.3 million women were diagnosed ...

... 22 Every year in Jacksonville,nearly 600 adults ... now,their long road to recovery lacked long-term support. ... the only program,in Florida created to help people ... community reintegration., The Brain Injury Association of ...

... physician, caregiver and pet therapy awards, MILWAUKEE, ... a,top national award from the Planetree organization. Aurora ... for Kradwell School at,Planetree,s national conference in Chicago ... dedicated to a,patient-centered, holistic approach to health care. ...

... Verification Safeguards Allow Thieves to Steal, SAN ... Americans,are the victims of identity theft, and in ... theft victim Eric Drew claims that the,credit industry ... by fully automating their identity verification systems, credit,card ...

Cached Medicine News:Health News:UNIVAL(R), Inc. Becomes a Microsoft(R) HealthVault(TM) Application Provider 2 Health News:Video Blog Chronicles One Woman's Fight Against Her Diabetes 2 Health News:The Pink Ribbon That Could Save Your Life 2 Health News:The Pink Ribbon That Could Save Your Life 3 Health News:Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida 2 Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 2 Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 3 Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 4 Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 5 Health News:Credit Card Companies Accomplices in Millions of Identity Theft Cases Alleges Eric Drew 2

UNIVAL(R), Inc. Becomes a Microsoft(R) HealthVault(TM) Application Provider Video Blog Chronicles One Woman's Fight Against Her Diabetes The Pink Ribbon That Could Save Your Life Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida Aurora Health Care's Kradwell School Receives National Planetree Award Credit Card Companies Accomplices in Millions of Identity Theft Cases Alleges Eric Drew

... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...

... for the visual, qualitative detection ... infectious mononucleosis in human serum, ... This test is intended as ... of infectious mononucleosis in patients ...

The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...

... Absorbable Hemostat is a purified and lyophilized ... a sponge-like pad, is lightly cross-linked, sterile, ... an inherent property of collagen, is largely ... this protein. The helical structure of native ...

Medicine Products:

The Acceava Mononucleosis test SureStep™ Mono Test NOW Flu B Test INSTAT Collagen Absorbable Hemostat